Muscle maturation: implications for gene therapy (Q44943020)

7 December 2017

1 reference

title

Muscle maturation: implications for gene therapy (English)

1 reference

7 December 2017

0 references

van Deutekom JC

1

1 reference

PubMed ID

9612801

7 December 2017

Hoffman EP

series ordinal

2

1 reference

PubMed ID

9612801

7 December 2017

Huard J

series ordinal

3

1 reference

7 December 2017

1 May 1998

1 reference

Trends in Molecular Medicine

7 December 2017

1 reference

7 December 2017

4

1 reference

7 December 2017

5

1 reference

7 December 2017

214-220

1 reference

Muscle-mediated gene therapy

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Muscle-based gene therapy: realistic possibilities for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Immunoelectron microscopic localization of dystrophin in myofibres

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Myoblast transfer in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Gene transfer into skeletal muscles by isogenic myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Myoblast transfer in the treatment of Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

The fate of individual myoblasts after transplantation into muscles of DMD patients

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Selection and use of ligands for receptor-mediated gene delivery to myogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Systemic delivery of recombinant proteins by genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Adenovirus as an expression vector in muscle cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Gene transfer to muscle using herpes simplex virus-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Recombinant adeno-associated virus for muscle directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Persistence in muscle of an adenoviral vector that lacks all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Assembly of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Gene transfer in regenerating muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901231-3

7 January 2021

10.1016/S1357-4310(98)01231-3

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

9612801